再致敏——在接受青霉素过敏评估的患者中是否应该进行重复测试?一场支持反对者的辩论。

IF 6.6 1区 医学 Q1 ALLERGY Journal of Allergy and Clinical Immunology-In Practice Pub Date : 2025-05-01 Epub Date: 2025-01-16 DOI:10.1016/j.jaip.2024.12.043
Ami P. Belmont MD , Roland Solensky MD , Inmaculada Doña MD, PhD , María Salas MD, PhD , María José Torres MD, PhD
{"title":"再致敏——在接受青霉素过敏评估的患者中是否应该进行重复测试?一场支持反对者的辩论。","authors":"Ami P. Belmont MD ,&nbsp;Roland Solensky MD ,&nbsp;Inmaculada Doña MD, PhD ,&nbsp;María Salas MD, PhD ,&nbsp;María José Torres MD, PhD","doi":"10.1016/j.jaip.2024.12.043","DOIUrl":null,"url":null,"abstract":"<div><div>Evaluating penicillin allergy labels and expanding access to preferred treatment options safely is of critical public health importance. Most patients with penicillin allergy labels are not allergic, and even in those with verified allergy, sensitization wanes over time. However, sensitization is complex, and whereas a patient may have a negative penicillin allergy evaluation (including a drug challenge), resensitization can occur, raising a risk of a subsequent reaction on exposure. In this pro–con debate we deliberate on whether patients who have had negative penicillin allergy evaluations should undergo retesting for sensitization before subsequent administrations. The pro position is presented by Drs Inmaculada Doña, María Salas, and María Torres, whereas the con position is described by Drs Ami Belmont and Roland Solensky.</div></div>","PeriodicalId":51323,"journal":{"name":"Journal of Allergy and Clinical Immunology-In Practice","volume":"13 5","pages":"Pages 1004-1010"},"PeriodicalIF":6.6000,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Resensitization—Should Repeat Testing Be Performed in Patients Undergoing Penicillin Allergy Evaluations? A Pro–Con Debate\",\"authors\":\"Ami P. Belmont MD ,&nbsp;Roland Solensky MD ,&nbsp;Inmaculada Doña MD, PhD ,&nbsp;María Salas MD, PhD ,&nbsp;María José Torres MD, PhD\",\"doi\":\"10.1016/j.jaip.2024.12.043\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><div>Evaluating penicillin allergy labels and expanding access to preferred treatment options safely is of critical public health importance. Most patients with penicillin allergy labels are not allergic, and even in those with verified allergy, sensitization wanes over time. However, sensitization is complex, and whereas a patient may have a negative penicillin allergy evaluation (including a drug challenge), resensitization can occur, raising a risk of a subsequent reaction on exposure. In this pro–con debate we deliberate on whether patients who have had negative penicillin allergy evaluations should undergo retesting for sensitization before subsequent administrations. The pro position is presented by Drs Inmaculada Doña, María Salas, and María Torres, whereas the con position is described by Drs Ami Belmont and Roland Solensky.</div></div>\",\"PeriodicalId\":51323,\"journal\":{\"name\":\"Journal of Allergy and Clinical Immunology-In Practice\",\"volume\":\"13 5\",\"pages\":\"Pages 1004-1010\"},\"PeriodicalIF\":6.6000,\"publicationDate\":\"2025-05-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Allergy and Clinical Immunology-In Practice\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2213219825000546\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/1/16 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q1\",\"JCRName\":\"ALLERGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Allergy and Clinical Immunology-In Practice","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2213219825000546","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/16 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"ALLERGY","Score":null,"Total":0}
引用次数: 0

摘要

评估青霉素过敏标签和扩大安全获得首选治疗方案对公共卫生至关重要。大多数有青霉素过敏标签的患者并不过敏,即使在那些证实过敏的患者中,敏化也会随着时间的推移而减弱。然而,致敏是复杂的,当患者可能有阴性青霉素过敏评估(包括药物挑战)时,可发生再致敏,增加暴露后后续反应的风险。在这个赞成/反对的辩论中,我们讨论了青霉素过敏评价阴性的患者是否应该在随后的给药前重新进行致敏试验。辩方由dr。Inmaculada Doña, María Salas和María Torres,而这种情况是由dr。Ami Belmont和Roland Solensky。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Resensitization—Should Repeat Testing Be Performed in Patients Undergoing Penicillin Allergy Evaluations? A Pro–Con Debate
Evaluating penicillin allergy labels and expanding access to preferred treatment options safely is of critical public health importance. Most patients with penicillin allergy labels are not allergic, and even in those with verified allergy, sensitization wanes over time. However, sensitization is complex, and whereas a patient may have a negative penicillin allergy evaluation (including a drug challenge), resensitization can occur, raising a risk of a subsequent reaction on exposure. In this pro–con debate we deliberate on whether patients who have had negative penicillin allergy evaluations should undergo retesting for sensitization before subsequent administrations. The pro position is presented by Drs Inmaculada Doña, María Salas, and María Torres, whereas the con position is described by Drs Ami Belmont and Roland Solensky.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
11.10
自引率
9.60%
发文量
683
审稿时长
50 days
期刊介绍: JACI: In Practice is an official publication of the American Academy of Allergy, Asthma & Immunology (AAAAI). It is a companion title to The Journal of Allergy and Clinical Immunology, and it aims to provide timely clinical papers, case reports, and management recommendations to clinical allergists and other physicians dealing with allergic and immunologic diseases in their practice. The mission of JACI: In Practice is to offer valid and impactful information that supports evidence-based clinical decisions in the diagnosis and management of asthma, allergies, immunologic conditions, and related diseases. This journal publishes articles on various conditions treated by allergist-immunologists, including food allergy, respiratory disorders (such as asthma, rhinitis, nasal polyps, sinusitis, cough, ABPA, and hypersensitivity pneumonitis), drug allergy, insect sting allergy, anaphylaxis, dermatologic disorders (such as atopic dermatitis, contact dermatitis, urticaria, angioedema, and HAE), immunodeficiency, autoinflammatory syndromes, eosinophilic disorders, and mast cell disorders. The focus of the journal is on providing cutting-edge clinical information that practitioners can use in their everyday practice or to acquire new knowledge and skills for the benefit of their patients. However, mechanistic or translational studies without immediate or near future clinical relevance, as well as animal studies, are not within the scope of the journal.
期刊最新文献
Emerging Therapies for Eosinophilic Gastrointestinal Disorders: How Can They Complement and Transform Current Care. Beyond Endoscopy, Toward Innovative Diagnosis and Monitoring of Eosinophilic Gastrointestinal Diseases. Hematopoietic Stem Cell Transplant for JAK-STAT Disorders. Application of T2 Biomarkers to Support Steroid Stewardship in Severe Asthma - a retrospective cohort study. When Knowing Costs Too Much: A Health-Economic Evaluation of Failed 95044 Reimbursement for Patch Testing in Allergic Contact Dermatitis.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1